Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: In vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737

被引：30

作者：

Ishitsuka, Kenji ^{[1
]}

Kunami, Naoko ^{[1
]}

Katsuya, Hiroo ^{[1
]}

Nogami, Rumiko ^{[1
]}

Ishikawa, Chie ^{[2
,3
]}

Yotsumoto, Fusanori ^{[4
]}

Tanji, Hiroe ^{[2
]}

Mori, Naoki ^{[2
]}

Takeshita, Morishige ^{[5
]}

Miyamoto, Shingo ^{[6
]}

Tamura, Kazuo ^{[1
]}

机构：

[1] Fukuoka Univ, Dept Internal Med, Div Med Oncol Hematol & Infect Dis, Fukuoka 8140180, Japan

[2] Univ Ryukyus, Grad Sch Med, Div Mol Virol & Oncol, Nishihara, Okinawa 9030215, Japan

[3] Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Nishihara, Okinawa 9030215, Japan

[4] Fukuoka Univ, Sch Med, Dept Biochem, Fukuoka 8140180, Japan

[5] Fukuoka Univ, Sch Med, Dept Pathol, Fukuoka 8140180, Japan

[6] Fukuoka Univ, Dept Obstet & Gynecol, Fukuoka 8140180, Japan

来源：

CANCER LETTERS | 2012年 / 317卷 / 02期

关键词：

ATLL; Novel treatment; Bcl-2 family proteins; Apoptosis; ABT-737; ACUTE LYMPHOBLASTIC-LEUKEMIA; MULTIPLE-MYELOMA CELLS; BH3 MIMETIC ABT-737; NF-KAPPA-B; CONSTITUTIVE ACTIVATION; DOWN-REGULATION; X-L; APOPTOSIS; LYMPHOMA; SENSITIVITY;

D O I：

10.1016/j.canlet.2011.11.030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell malignancy caused by human T-lymphotropic virus type 1 (HTLV-1). ABT-737, a small molecule inhibitor of Bcl-2, Bcl-X-L, and Bcl-w, significantly induced apoptosis in HTLV-1 infected T-cell lines as well as in fresh ATLL cells, and synergistically enhanced the cytotoxicity and apoptosis induced by conventional cytotoxic drugs. Moreover, ABT-737 significantly inhibited the in vivo tumor growth of an ATLL mouse model. These results suggest that the use of an agent targeting anti-apoptotic bcl-2 family proteins, either alone or in combination with other conventional drugs, represents a novel promising approach for ATLL (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：218 / 225

页数：8

共 50 条

[1] Targeting Bcl-2 Family Proteins in Adult T-Cell Leukemia/Lymphoma: In Vitro and In Vivo Effects of a Novel Bcl-2 Family Inhibitor ABT-737.
Ishitsuka, Kenji
Ishikawa, Chie
Yotsumoto, Fusanori
Katsuya, Hiroo
Kunami, Naoko
Sawada, Shigeki
Tanji, Hiroe
Takeshita, Morishige
Miyamoto, Shingo
Mori, Naoki
Tamura, Kazuo
[J]. BLOOD, 2009, 114 (22) : 672 - 672
[2] A Promising Therapeutic Implication of a Novel Bcl-2 Family Inhibitor ABT-737 for Adult T-Cell Leukemia/Lymphoma
Ishittsuka, Kenji
Yotsumoto, Fusanori
Katsuya, Hiroo
Ushijima, Emiko
Miyamoto, Shingo
Tamura, Kazuo
[J]. BLOOD, 2008, 112 (11) : 562 - 562
[3] Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737
Jayanthan, Aarthi
Howard, Scott C.
Trippett, Tanya
Horton, Terzah
Whitlock, James A.
Daisley, Lara
Lewis, Victor
Narendran, Aru
[J]. LEUKEMIA & LYMPHOMA, 2009, 50 (07) : 1174 - 1182
[4] ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells
M P Kline
S V Rajkumar
M M Timm
T K Kimlinger
J L Haug
J A Lust
P R Greipp
S Kumar
[J]. Leukemia, 2007, 21 : 1549 - 1560
[5] MEDI 18-Discovery of ABT-737, an inhibitor of Bcl-2 family proteins that promotes apoptosis
Wendt, Michael D.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[6] ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells
Kline, M. P.
Rajkumar, S. V.
Timm, M. M.
Kimlinger, T. K.
Haug, J. L.
Lust, J. A.
Greipp, P. R.
Kumar, S.
[J]. LEUKEMIA, 2007, 21 (07) : 1549 - 1560
[7] Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
Tagscherer, K. E.
Fassl, A.
Campos, B.
Farhadi, M.
Kraemer, A.
Boeck, B. C.
Macher-Goeppinger, S.
Radlwimmer, B.
Wiestler, O. D.
Herold-Mende, C.
Roth, W.
[J]. ONCOGENE, 2008, 27 (52) : 6646 - 6656
[8] Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
K E Tagscherer
A Fassl
B Campos
M Farhadi
A Kraemer
B C Böck
S Macher-Goeppinger
B Radlwimmer
O D Wiestler
C Herold-Mende
W Roth
[J]. Oncogene, 2008, 27 : 6646 - 6656
[9] The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin
Witham, James
Valenti, Melanie R.
De-Haven-Brandon, Alexis K.
Vidot, Susanne
Eccles, Suzanne A.
Kaye, Stan B.
Richardson, Alan
[J]. CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7191 - 7198
[10] Promise of Combining a Bcl-2 Family Inhibitor with Bortezomib or SAHA for Adult T-cell Leukemia/Lymphoma
Kunami, Naoko
Katsuya, Hiroo
Nogami, Rumiko
Ishitsuka, Kenji
Tamura, Kazuo
[J]. ANTICANCER RESEARCH, 2014, 34 (10) : 5287 - 5294

← 1 2 3 4 5 →